Connection

Philip Hall to Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Back to Details
This is a "connection" page, showing publications Philip Hall has written about Leukemia, Myelogenous, Chronic, BCR-ABL Positive.
Philip Hall
Connection Strength
0.529
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  1. Experience with dasatinib and nilotinib use in pregnancy. J Oncol Pharm Pract. 2018 Mar; 24(2):121-128.
    View in: PubMed
    Score: 0.529
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.